1. Home
  2. |Insights
  3. |Crowell & Moring Advises Cure Ventures in Series A Financing of Tortugas Neuroscience

Crowell & Moring Advises Cure Ventures in Series A Financing of Tortugas Neuroscience

Firm News | less than 1 min read | 04.21.26

Boston – April 21, 2026: Crowell & Moring advised founding investor Cure Ventures in the Series A financing of Tortugas Neuroscience, a neurology-focused biotech company.  

Cure Ventures co-led the Series A round in partnership with The Column Group and AN Venture Partners. Proceeds from the financing will support Tortugas’ ongoing research and development initiatives regarding new and major neurology and neuropsychiatric disorders, including the completion of Phase 2 clinical trials for its two lead candidates. 

The financing transaction was led by partner  Kurt Machemer (Boston). 
 
Read more here. 

Insights

Firm News | 2 min read | 05.13.26

Crowell & Moring Opens Office in Minneapolis

Washington – May 13, 2026: Crowell & Moring has opened a new office in Minneapolis, Minnesota, with a focus on the firm’s regulatory, enforcement and litigation strengths in areas including health care, antitrust and competition, and labor and employment. The office launches with an initial team of eight attorneys, including partners Toni Michelle Jackson and Jeff Gleason, with additional growth anticipated in the near term. Minneapolis is Crowell’s 13th office and follows office openings last year in Boston and Dallas....

View All Insights